Against working memory impairment‐like behaviours, unlike against anxiety‐like behaviours, ameliorating effects were induced by the CB1 antagonist SR, for which combined involvement of the complementary neurotransmitter systems,102, 103, 104 along with specific biochemical/neurophysiological modifications in memory‐related brain regions,105, 106 could be assumed. The gene discussed is CNR1; the disease is Anxiety.